200,000+ products from a single source!

sales@angenechem.com

Home > Thiazole > 255-17-4

255-17-4

255-17-4 | 2H-1,4-Benzothiazine(8CI,9CI)

CAS No: 255-17-4 Catalog No: AG007MSU MDL No:MFCD15203727

Product Description

Catalog Number:
AG007MSU
Chemical Name:
2H-1,4-Benzothiazine(8CI,9CI)
CAS Number:
255-17-4
Molecular Formula:
C8H7NS
Molecular Weight:
149.2129
MDL Number:
MFCD15203727
IUPAC Name:
2H-1,4-benzothiazine
InChI:
InChI=1S/C8H7NS/c1-2-4-8-7(3-1)9-5-6-10-8/h1-5H,6H2
InChI Key:
FBOSKQVOIHEWAX-UHFFFAOYSA-N
SMILES:
C1=Nc2c(SC1)cccc2

Properties

Complexity:
144  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
149.03g/mol
Formal Charge:
0
Heavy Atom Count:
10  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
149.211g/mol
Monoisotopic Mass:
149.03g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
37.7A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.7  

Literature

Title Journal
Functionalized 1,4-benzothiazine: a versatile scaffold with diverse biological properties. Archiv der Pharmazie 20121101
Biosynthetic pathway to neuromelanin and its aging process. Pigment cell & melanoma research 20121101
UVA-induced oxidative degradation of melanins: fission of indole moiety in eumelanin and conversion to benzothiazole moiety in pheomelanin. Pigment cell & melanoma research 20120701
4H-1,4-benzothiazine, dihydro-1,4-benzothiazinones and 2-amino-5-fluorobenzenethiol derivatives: design, synthesis and in vitro antimicrobial screening. Archiv der Pharmazie 20120501
2,3-Dihydro-1λ(6),2-benzothia-zine-1,1,4-trione. Acta crystallographica. Section E, Structure reports online 20120501
(2-Chloro-phen-yl)(4-hy-droxy-1,1-dioxo-2H-1,2-benzothia-zin-3-yl)methanone. Acta crystallographica. Section E, Structure reports online 20120501
[2-(2,5-Dichloro-benz-yl)-4-hy-droxy-1,1-dioxo-2H-1,2-benzothia-zin-3-yl](phen-yl)methanone. Acta crystallographica. Section E, Structure reports online 20120501
1-(4-Chloro-phen-yl)-2-[4-hy-droxy-3-(3-meth-oxy-benzo-yl)-1,1-dioxo-2H-1λ(6),2-benzothia-zin-2-yl]ethanone. Acta crystallographica. Section E, Structure reports online 20120401
3-[Hy-droxy(3-meth-oxy-phen-yl)methyl-idene]-2-(2-oxo-2-phenyl-eth-yl)-3,4-dihydro-2H-1λ(6),2-benzothia-zine-1,1,4-trione. Acta crystallographica. Section E, Structure reports online 20120401
2-[2-(3-Chloro-phen-yl)-2-oxoeth-yl]-4-hy-droxy-3-(3-meth-oxy-benzo-yl)-2H-1λ(6),2-benzothia-zine-1,1-dione. Acta crystallographica. Section E, Structure reports online 20120401
(2-Bromo-phen-yl)(4-hy-droxy-1,1-dioxo-2H-1,2-benzothia-zin-3-yl)methanone. Acta crystallographica. Section E, Structure reports online 20120401
2-(N-Cyclo-hexyl-carbamo-yl)benzene-sulfonamide. Acta crystallographica. Section E, Structure reports online 20120201
2-(3,4-Dimethyl-5,5-dioxo-2H,4H-pyrazolo-[4,3-c][1,2]benzothia-zin-2-yl)-1-(4-meth-oxy-phen-yl)ethanone. Acta crystallographica. Section E, Structure reports online 20120201
3,4-Dimethyl-2-(2-oxo-2-phenyl-eth-yl)-2H,4H-pyrazolo-[4,3-c][1,2]benzothia-zine-5,5-dione. Acta crystallographica. Section E, Structure reports online 20120201
3-[(3-Benzoyl-4-hy-droxy-1,1-dioxo-2H-1λ,2-benzothia-zin-2-yl)meth-yl]benzo-nitrile. Acta crystallographica. Section E, Structure reports online 20120101
2-(3-Benzoyl-4-hy-droxy-1,1-dioxo-2H-1λ,2-benzothia-zin-2-yl)-1-phenyl-ethanone. Acta crystallographica. Section E, Structure reports online 20120101
1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase. Bioorganic & medicinal chemistry 20111201
N'-[(E)-1-(4-Bromo-phen-yl)ethyl-idene]-4-hy-droxy-2-methyl-1,1-dioxo-2H-1,2-benzothia-zine-3-carbohydrazide. Acta crystallographica. Section E, Structure reports online 20111001
Novel benzoxazine and benzothiazine derivatives as multifunctional antihyperlipidemic agents. Journal of medicinal chemistry 20110811
6-Bromo-4-hydrazinyl-idene-1-methyl-3H-2λ,1-benzothia-zine-2,2-dione. Acta crystallographica. Section E, Structure reports online 20110801
Methyl 2-benzyl-4-hy-droxy-1,1-dioxo-1,2,3,4-tetra-hydro-1λ,2-benzothia-zine-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110701
Methyl 4-hy-droxy-2-isopropyl-1,1-dioxo-2H-1,2-benzothia-zine-3-carboxyl-ate. Acta crystallographica. Section E, Structure reports online 20110701
Methyl 2-(3-oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetate. Acta crystallographica. Section E, Structure reports online 20110301
Synthesis of new 2-substituted 6-bromo-3-methylthiazolo[3,2-alpha]-benzimidazole derivatives and their biological activities. Zeitschrift fur Naturforschung. C, Journal of biosciences 20110101
Antiviral drugs against hepatitis C virus. Genetic vaccines and therapy 20110101
Bioactive pigments from marine bacteria: applications and physiological roles. Evidence-based complementary and alternative medicine : eCAM 20110101
1-Propyl-1H-2,1-benzothia-zin-4(3H)-one 2,2-dioxide. Acta crystallographica. Section E, Structure reports online 20101101
Synthesis and antioxidant activity of quinolinobenzothiazinones. European journal of medicinal chemistry 20101001
Isoprop-yl (3,4-dimethyl-5,5-dioxo-4H-pyrazolo-[4,3-c][1,2]benzothia-zin-2-yl)acetate. Acta crystallographica. Section E, Structure reports online 20101001
2-(3-Oxo-3,4-dihydro-2H-1,4-benzothia-zin-4-yl)acetohydrazide. Acta crystallographica. Section E, Structure reports online 20100901
4-Hy-droxy-3-(3-meth-oxybenzoyl)-2-[(3-meth-oxybenzoyl)methyl]-2H-1,2-benzothia-zine 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20100901
4-Hy-droxy-2-[(4-iodo-benzo-yl)meth-yl]-3-(3-meth-oxy-benzo-yl)-2H-1,2-benzothia-zine 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20100901
Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs. The Journal of pharmacy and pharmacology 20100701
Ultrasound-promoted greener synthesis of benzoheterocycle derivatives catalyzed by nanocrystalline copper(II) oxide. Ultrasonics sonochemistry 20100601
(4-Hydr-oxy-1,1-dioxo-2H-1,2-benzothia-zin-3-yl)(3-methoxy-phen-yl)methanone. Acta crystallographica. Section E, Structure reports online 20100501
3-Benzoyl-4-hydr-oxy-2H-1,2-benzothia-zine 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20100401
3-(3-Chloro-benzo-yl)-4-hydr-oxy-2H-1,2-benzothia-zine 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20100401
3-Benzoyl-4-hydr-oxy-2-methyl-2H-1,2-benzothia-zine 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20100401
Methyl 2-[(methyl-sulfon-yl)(prop-yl)amino]benzoate. Acta crystallographica. Section E, Structure reports online 20100101
The hunt for natural skin whitening agents. International journal of molecular sciences 20091201
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 3: synthesis and optimization studies of benzothiazine-substituted tetramic acids. Bioorganic & medicinal chemistry letters 20091001
A nonmerohedral twin of methyl 2-[meth-yl(methyl-sulfon-yl)amino]benzoate. Acta crystallographica. Section E, Structure reports online 20091001
Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. International journal of molecular sciences 20090901
Chemical analysis of late stages of pheomelanogenesis: conversion of dihydrobenzothiazine to a benzothiazole structure. Pigment cell & melanoma research 20090801
2-(Methoxy-carbon-yl)anilinium dihydrogen phosphate. Acta crystallographica. Section E, Structure reports online 20090801
Non-nucleoside inhibitors of HCV NS5B polymerase. Part 1: Synthetic and computational exploration of the binding modes of benzothiadiazine and 1,4-benzothiazine HCV NS5b polymerase inhibitors. Bioorganic & medicinal chemistry letters 20090701
6-Bromo-3,3-dichloro-1-methyl-1H-2,1-benzothia-zin-4(3H)-one 2,2-dioxide. Acta crystallographica. Section E, Structure reports online 20090601
6-Bromo-1-methyl-1H-2,1-benzothia-zin-4(3H)-one 2,2-dioxide. Acta crystallographica. Section E, Structure reports online 20090501
Methyl 5-bromo-2-[meth-yl(methyl-sulfon-yl)amino]benzoate. Acta crystallographica. Section E, Structure reports online 20090501
Benzothiazines in synthesis. Further studies of the intramolecular, stereoselective addition of sulfonimidoyl carbanions to alpha,beta-unsaturated functional groups. The Journal of organic chemistry 20090417
Methyl 2-(N-methoxy-carbonyl-meth-yl-N-methylsulfamo-yl)benzoate. Acta crystallographica. Section E, Structure reports online 20090301
6-Bromo-1-ethyl-1H-2,1-benzothia-zin-4(3H)-one 2,2-dioxide. Acta crystallographica. Section E, Structure reports online 20090201
Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors. PloS one 20090101
Sodium 2-iodo-benzene-sulfonate monohydrate. Acta crystallographica. Section E, Structure reports online 20081201
Methyl 3-hydr-oxy-4-oxo-3,4-dihydro-2H-1,2-benzothia-zine-3-carboxyl-ate 1,1-dioxide monohydrate. Acta crystallographica. Section E, Structure reports online 20081001
Novel 1,4-benzothiazine derivatives as large conductance Ca2+-activated potassium channel openers. Journal of medicinal chemistry 20080828
Potassium 2-iodo-benzene-sulfonate monohydrate. Acta crystallographica. Section E, Structure reports online 20080801
Methyl 4-eth-oxy-2-methyl-2H-1,2-benzothia-zine-3-carboxyl-ate 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20080801
From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump. Journal of medicinal chemistry 20080724
N-Butyl-4-hydr-oxy-2-methyl-2H-1,2-benzothia-zine-3-carboxamide 1,1-dioxide. Acta crystallographica. Section E, Structure reports online 20080701
(2E)-2-(2,4-Dichloro-phenyl-sulfon-yl)-3-(3-methoxy-anilino)-3-(methyl-sulfan-yl)acrylonitrile. Acta crystallographica. Section E, Structure reports online 20080601
(2E)-2-(2,4-Dichloro-phenyl-sulfon-yl)-3-(4-methyl-anilino)-3-(methyl-sulfan-yl)acrylonitrile. Acta crystallographica. Section E, Structure reports online 20080601
1-(4-Hydr-oxy-2-methyl-1,1-dioxo-2H-1,2-benzothia-zin-3-yl)ethanone. Acta crystallographica. Section E, Structure reports online 20080501
Molecular and crystalline structure of cycloheptanespiro-3'(4'H)-6',7',8',9'-tetrahydrocyclohexa[b][1,4]thiazole-2'(5'H)-thione from powder synchrotron X-ray diffraction data. Acta crystallographica. Section B, Structural science 20080401
1-Ethyl-1H-2,1-benzothia-zin-4(3H)-one 2,2-dioxide. Acta crystallographica. Section E, Structure reports online 20080301
Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice. The Journal of biological chemistry 20080222
Counterions influence reactivity of metal ions with cysteinyldopa model compounds. Inorganic chemistry 20080204
The 'benzothiazine' chromophore of pheomelanins: a reassessment. Photochemistry and photobiology 20080101
Benzothiazines in organic synthesis. Stereoselectivity in the intermolecular Michael addition reactions of benzothiazines. Organic letters 20071108
Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moiety. Bioorganic & medicinal chemistry letters 20070901
Oxime and oxime ether derivatives of 1,4-benzothiazine related to oxiconazole. ChemMedChem 20070801
Design and synthesis of pyrimido[4,5-b][1,4]benzothiazine derivatives, as potent 15-lipoxygenase inhibitors. Bioorganic & medicinal chemistry 20070301
Ionizing radiation changes the electronic properties of melanin and enhances the growth of melanized fungi. PloS one 20070101
Synthesis and characterization of copper(II) complexes of cysteinyldopa and benzothiazine model ligands related to pheomelanin. Inorganic chemistry 20060807
Novel ketoconazole analogues based on the replacement of 2,4-dichlorophenyl group with 1,4-benzothiazine moiety: design, synthesis, and microbiological evaluation. Bioorganic & medicinal chemistry 20060801
New chiral benzothiazine ligand and its use in the synthesis of a chiral receptor. The Journal of organic chemistry 20060428
Photoionization thresholds of melanins obtained from free electron laser-photoelectron emission microscopy, femtosecond transient absorption spectroscopy and electron paramagnetic resonance measurements of oxygen photoconsumption. Photochemistry and photobiology 20060101
Role of 1,4-benzothiazine derivatives in medicinal chemistry. Mini reviews in medicinal chemistry 20051201
Synthesis of 2H-1,2-benzothiazine 1,1-dioxides via heteroannulation reactions of 2-iodobenzenesulfonamide with ketone enolates under S(RN)1 conditions. The Journal of organic chemistry 20051111
Design and evaluation of dihydroxytetrahydro-1H-pyrrolo[2,1-c]- [1,4]benzothiazines as conformationally restricted transition-state inhibitors of beta-ribosidases. The Journal of organic chemistry 20051028
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K(ATP)-channel openers. Bioorganic & medicinal chemistry 20051001
Benzothiazines in synthesis. A total synthesis of pseudopteroxazole. Organic letters 20050804
Benzothiazines in synthesis. Toward the synthesis of pseudopteroxazole. Organic letters 20040624
HPLC analysis of pheomelanin degradation products in human urine. Pigment cell research 20031001
1,4-benzothiazines as key intermediates in the biosynthesis of red hair pigment pheomelanins. Pigment cell research 20031001
Highly potent 1,4-benzothiazine derivatives as K(ATP)-channel openers. Journal of medicinal chemistry 20030814
The structure of neuromelanin as studied by chemical degradative methods. Journal of neurochemistry 20030801
1,4-benzothiazine analogues and apoptosis: structure-activity relationship. Bioorganic & medicinal chemistry 20030731
Synthesis of 4-octyl-2H-1,4-benzo-thiazin-3-ones. European journal of medicinal chemistry 20030101
1,4-Benzothiazine and 1,4-benzoxazine imidazole derivatives with antifungal activity: a docking study. Bioorganic & medicinal chemistry 20021101
Metal ions as potential regulatory factors in the biosynthesis of red hair pigments: a new benzothiazole intermediate in the iron or copper assisted oxidation of 5-S-cysteinyldopa. Biochimica et biophysica acta 20020606
Anti-Candida albicans properties of novel benzoxazine analogues. Bioorganic & medicinal chemistry 20020601
The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin. Pigment cell research 20020601
Antiplatelet activity of semotiadil fumarate. Thrombosis research 20020515
Induction of apoptosis by 1,4-benzothiazine analogs in mouse thymocytes. The Journal of pharmacology and experimental therapeutics 20020301
Intramolecular capture of pummerer reaction intermediates by an aromatic nucleophile: selective construction of 1,4-benzothiazine and indole ring systems. Chemical & pharmaceutical bulletin 20010901
Antifungal and immunomodulating activities of 1,4-benzothiazine azole derivatives: review. Journal of chemotherapy (Florence, Italy) 20010201

Related Products

© 2019 Angene International Limited. All rights Reserved.